Longitudinal improvements in clinical and functional outcomes following initiation of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis

Background: Use of elexacaftor/tezacaftor/ivacaftor (ETI) for treatment of cystic fibrosis (CF) has resulted in unprecedented clinical improvements necessitating development of outcome measures for monitoring disease course. Intranasal micro-optical coherence tomography (μOCT) has previously helped...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Kadambari Vijaykumar, Hui Min Leung, Amilcar Barrios, Justin Wade, Heather Y. Hathorne, David P. Nichols, Guillermo J. Tearney, Steven M. Rowe, George M. Solomon
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Elsevier 2024-04-01
Serie:	Heliyon
Ämnen:	Cystic fibrosis Highly effective modulator therapies Micro-optical coherence tomography Mucociliary abnormalities
Länkar:	http://www.sciencedirect.com/science/article/pii/S2405844024052198
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!